Evidence map›Paper›PMID 29769842›Full record

ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2014

Lyme disease: clinical diagnosis and treatment.

T F Hatchette, I Davis, B L Johnston

Open access · diamondAbstract read
In one paragraph

Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Persistent bradycardia requiring temporary pacing in a young adult with lyme carditis: a case report.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Atypical presentation of Lyme disease in a returning traveler: a case report.Tropical diseases, travel medicine and vaccines · 2025
    Article
  9. Silent Spread ofHealthcare (Basel, Switzerland) · 2025
    Article
  10. Anaplasmosis: Emerging threat in Canada.Canadian family physician Medecin de famille canadien · 2025
    Review
  11. Article
  12. Synthesis of aMolecules (Basel, Switzerland) · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Surveillance for Lyme disease in Canada, 2009-2019.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2022
    Article
  18. Introduction of IgM testing for the diagnosis of acute Lyme borreliosis: a study of the benefits, limitations and costs.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

T F HatchetteDepartment of Pathology and Laboratory Medicine, Capital District Health Authority (CDHA), Halifax, Nova Scotia.
I DavisDepartment of Pathology and Laboratory Medicine, Capital District Health Authority (CDHA), Halifax, Nova Scotia.
B L JohnstonDepartment of Medicine, CDHA and Dalhousie University, Halifax, Nova Scotia.
Dalhousie University · CACapital Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLyme disease is an emerging zoonotic infection in Canada. As the

objectiveTo review the clinical diagnosis and treatment of Lyme disease for front-line clinicians.

methodsA literature search using PubMed and restricted to articles published in English between 1977 and 2014.

resultsIndividuals in Lyme-endemic areas are at greatest risk, but not all tick bites transmit Lyme disease. The diagnosis is predominantly clinical. Patients with Lyme disease may present with early disease that is characterized by a "bull's eye rash", fever and myalgias or with early disseminated disease that can manifest with arthralgias, cardiac conduction abnormalities or neurologic symptoms. Late Lyme disease in North America typically manifests with oligoarticular arthritis but can present with a subacute encephalopathy. Antibiotic treatment is effective against Lyme disease and works best when given early in the infection. Prophylaxis with doxycyline may be indicated in certain circumstances. While a minority of patients may have persistent symptoms, evidence does not demonstrate that prolonged courses of antibiotics improve outcome.

conclusionClinicians need to be aware of the signs and symptoms of Lyme disease. Knowing the regions where

Identifiers

PMID29769842
PMCPMC5864449
OpenAlexW2183576586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.